AWARDDEFINITIVE CONTRACTOther than small business
Definitive contract HHSN272201800004CDUKE UNIVERSITY
Overview
Award facts
- Net obligations
- $17.98M
- $17,977,570of $19.83M potential value
- Outlays (paid to date)
- $10.34M
- $10.34M paid of $17.98M obligated$10,343,688
- Period of performance
- Mar 28, 2018 to Mar 29, 2025
- Ended
- Modifications
- 17
- Latest action Jun 17, 2026
- Contract type
- Definitive contract
- PIID HHSN272201800004C
Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.
Description of requirement
IGF::OT::IGF NONHUMAN PRIMATE CORE HUMORAL IMMUNOLOGY LABORATORY FOR AIDS VACCINE RESEARCH AND DEVELOPMENT
Dates and value
- Award date
- Signed on Mar 28, 2018
- Current value
- $17,977,570Base and exercised options
- Potential value (if all options are exercised)
- $19,829,466
Obligations by fiscal year of action
- FY2026: -$134 (de-obligation)
- FY2025: -$133,149 (de-obligation)
- FY2024: $2,567,540
- FY2023: $2,506,337
- FY2022: $2,666,257
- FY2021: $2,381,930
- FY2020: $3,317,991
- FY2019: $2,365,060
Show all 9 yearsEarlier years (FY2018–FY2018)
- FY2018: $2,305,737
Total across 9 fiscal years: $17,977,570
Net de-obligation in that fiscal year (obligations withdrawn).
Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Jun 17, 2026. View on USAspending · Recipient on SAM.gov
Recipient
NameDUKE UNIVERSITY
LocationDURHAM, NC
UEITP7EK8DZV6N5
CAGE code4B478
Business sizeOther than small businessSize at award, per the contracting officer
Organization typeCorporate tax exempt
Parent companyDUKE UNIVERSITY
Business types and certifications
Nonprofit organizationEducational institutionTax-exempt corporation
As represented in SAM.gov at the time of the action.
Subcontracting network
The prime, the subcontractors on this award, and their own subcontractors.
Agency and place
Awarding and funding
- Awarded by
- Department of Health and Human Services
- National Institutes Of Health
- NATIONAL INSTITUTES OF HEALTH NIAID
- Funded by
- Department of Health and Human Services
- National Institutes Of Health
- NATIONAL INSTITUTES OF HEALTH NIAID
- Funded from
- National institute of allergy and infectious diseases (0885)Program activities075-0885Federal accounts (agency financial reports)
Place of performance
- Place of performance
- Durham, North Carolina 27701-3606
- Congressional district (place of performance)
- NC-04As reported at the time of the action
Classification and competition
Classification
- Product or service (PSC)
- AN12HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH (research and development)
Competition
- Extent competed
- Full and open competitionA
- Solicitation procedures
- Negotiated proposal/quoteNP
- Set-aside
- No set-aside used
- Contract pricing
- Cost no feeS
- Offers received
- 1
Solicitation and notices
- Solicitation ID
- NIAIDDAIDSNIHAI2016071(as reported)
Contract details
- Subcontracting plan
- Individual subcontract planF
- Major program
- Nonhuman primate core humoral immunology laboratory for aids vaccine research and development
- Cost Accounting Standards clause
- Yes - CAS clause includedY
- Certified cost or pricing data
- No
- Commercial procedures
- Commercial products/services procedures not usedD
- Government-furnished property
- Transaction does not use GFE/GFPN
- Bundled requirement
- Not bundledH
- Consolidated requirement
- Not consolidatedD
- Undefinitized action (terms not final)
- No
- Multi-year contract
- No
- Performance-based service acquisition
- No - service where PBA is not used.N
Linked notices
Notice | Notice ID | Type | Link | Posted |
|---|---|---|---|---|
Transaction history
Modification history
- Base award
- Mar 28, 2018Base obligation at award: $2,205,512
- Latest action
- Jun 17, 2026 — Funding onlyModification P00017; obligation change -$134; funding only: changes obligations, not scope
- Latest substantive action
- Mar 14, 2024 — Option exercisedModification P00015; obligation change +$2,573,073
- Latest funding action
- Jun 17, 2026 — Funding onlyModification P00017; obligation change -$134; funding only: changes obligations, not scope
- Actions by type
- Base award1
- Option exercised8
- Funding only4
- Other administrative action4
- New work added (outside scope)1
Similar awards
PIID | Match | Awardee |
|---|---|---|
All contract data
All contract data
Every other field reported for this award, as of its latest reported action
Competition
- Evaluation preference
- No preference used
- Local area set-aside
- No
- Synopsized publicly (SAM.gov / FedBizOpps)
- Yes
- Simplified procedures for commercial items
- No
- A-76 (FAIR Act) action
- No
Pricing and financing
- Paid by purchase card
- No
- Latest action: change in base and exercised options
- -$134
- Latest action: change in base and all options
- -$134
Socio-economic and policy
- Inherently governmental functions
- Other functionsOT
- Recovered materials and sustainability
- No clauses included and no sustainability includedC
- EPA-designated product
- Not requiredE
- Clinger-Cohen Act planning (IT)
- No
Place and origin
- Domestic or foreign entity
- Other U.S. entity (e.g. government)B
- Country of product or service origin
- United statesUSA
- Place of manufacture
- Not a manufactured end productC
Structure
- Award or IDV
- Award
- Award type
- Definitive contractD
- Awarding agency code
- 7500
- Awarding sub-tier code
- 7529
- Contracting office code
- 75N930
- Transactions recorded under this award key
- 18
Funding
- Funding agency code
- 7500
- Funding sub-tier code
- 7529
- Funding office code
- 75N930
- Treasury accounts
- 075-2018/2018-0885-000
- 075-2019/2019-0885-000
- 075-2020/2020-0885-000
- 075-2020/2024-0885-000
- 075-2021/2021-0885-000
- 075-2022/2022-0885-000
Show all 8 accounts
- 075-2023/2023-0885-000
- 075-2024/2024-0885-000
- Object classes
- 25.5: Research and development contracts
- Disaster or emergency funding (DEFC)
- L: Emergency P.L. 116-123
- Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression
- COVID-19 supplemental obligations
- $996,426
- COVID-19 supplemental outlays
- $973,566